Hypoxia, often associated with adverse environmental conditions, has recently emerged as a significant player in the progression of colon cancer. Once considered mainly a problem in cancer treatment due to its potential to inhibit tumor growth by starving the cancer cells of oxygen, new insights
Ivan Kairatov is a renowned expert in biopharma, with a strong track record in research and development, particularly in technological innovations that drive pharmaceutical advancements. With his deep understanding of these domains, Ivan offers insights into groundbreaking studies and developments,
Can a newly discovered genetic syndrome completely reshape how cancer is treated? The emergence of DIAL syndrome, which impairs DNA repair mechanisms and elevates cancer risk, presents that possibility, stirring curiosity among researchers and medical professionals. The revelation raises an
In today's interview, we have the pleasure of speaking with Ivan Kairatov, a biopharma expert renowned for his expertise in technology and innovation within the industry. With extensive experience in research and development, Ivan provides invaluable insights into the current challenges and
Heart failure is emerging as a critical battlefield in modern medicine, with a striking gap in specialist care endangering patient survival. While cancer patients routinely receive oncological consultations, heart failure patients often lack consistent access to cardiologists. Research by French
Breast cancer remains the leading cancer diagnosis in women globally, presenting significant challenges due to its heterogeneity and biological complexity. This diversity in tumor types and characteristics demands innovative therapeutic approaches beyond traditional treatments. In recent years,
